tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2022 Apr 18;9(6)
fac138.
doi: 10.1093/ofid/ofac138. eCollection 2022 Jun.
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M Higdon[SUP] 1 [/SUP], Brian Wahl[SUP] 1 [/SUP], Carli B Jones[SUP] 2 [/SUP], Joseph G Rosen[SUP] 1 [/SUP], Shaun A Truelove[SUP] 1 [/SUP], Anurima Baidya[SUP] 3 [/SUP], Anjalika A Nande[SUP] 4 [/SUP], Parisa A ShamaeiZadeh[SUP] 3 [/SUP], Karoline K Walter[SUP] 3 [/SUP], Daniel R Feikin[SUP] 5 [/SUP], Minal K Patel[SUP] 5 [/SUP], Maria Deloria Knoll[SUP] 1 [/SUP], Alison L Hill[SUP] 4 [/SUP]
Affiliations
Abstract
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence and severity in some settings. Many studies suggest vaccines provide a high degree of protection against infection and disease, but precise estimates vary and studies differ in design, outcomes measured, dosing regime, location, and circulating virus strains. In this study, we conduct a systematic review of COVID-19 vaccines through February 2022. We included efficacy data from Phase 3 clinical trials for 15 vaccines undergoing World Health Organization Emergency Use Listing evaluation and real-world effectiveness for 8 vaccines with observational studies meeting inclusion criteria. Vaccine metrics collected include protection against asymptomatic infection, any infection, symptomatic COVID-19, and severe outcomes including hospitalization and death, for partial or complete vaccination, and against variants of concern Alpha, Beta, Gamma, Delta, and Omicron. We additionally review the epidemiological principles behind the design and interpretation of vaccine efficacy and effectiveness studies, including important sources of heterogeneity.
Keywords: COVID-19; SARS-CoV-2; systematic review; vaccine effectiveness; vaccine efficacy.
. 2022 Apr 18;9(6)
fac138.doi: 10.1093/ofid/ofac138. eCollection 2022 Jun.
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M Higdon[SUP] 1 [/SUP], Brian Wahl[SUP] 1 [/SUP], Carli B Jones[SUP] 2 [/SUP], Joseph G Rosen[SUP] 1 [/SUP], Shaun A Truelove[SUP] 1 [/SUP], Anurima Baidya[SUP] 3 [/SUP], Anjalika A Nande[SUP] 4 [/SUP], Parisa A ShamaeiZadeh[SUP] 3 [/SUP], Karoline K Walter[SUP] 3 [/SUP], Daniel R Feikin[SUP] 5 [/SUP], Minal K Patel[SUP] 5 [/SUP], Maria Deloria Knoll[SUP] 1 [/SUP], Alison L Hill[SUP] 4 [/SUP]
Affiliations
- PMID: 35611346
- PMCID: PMC9047227
- DOI: 10.1093/ofid/ofac138
Abstract
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence and severity in some settings. Many studies suggest vaccines provide a high degree of protection against infection and disease, but precise estimates vary and studies differ in design, outcomes measured, dosing regime, location, and circulating virus strains. In this study, we conduct a systematic review of COVID-19 vaccines through February 2022. We included efficacy data from Phase 3 clinical trials for 15 vaccines undergoing World Health Organization Emergency Use Listing evaluation and real-world effectiveness for 8 vaccines with observational studies meeting inclusion criteria. Vaccine metrics collected include protection against asymptomatic infection, any infection, symptomatic COVID-19, and severe outcomes including hospitalization and death, for partial or complete vaccination, and against variants of concern Alpha, Beta, Gamma, Delta, and Omicron. We additionally review the epidemiological principles behind the design and interpretation of vaccine efficacy and effectiveness studies, including important sources of heterogeneity.
Keywords: COVID-19; SARS-CoV-2; systematic review; vaccine effectiveness; vaccine efficacy.